ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $55,000 | -79.6% | 18,200 | -50.0% | 0.00% | -100.0% |
Q2 2019 | $269,000 | -63.4% | 36,400 | +41.5% | 0.00% | -75.0% |
Q1 2019 | $735,000 | +121.4% | 25,727 | +14.9% | 0.00% | +100.0% |
Q4 2018 | $332,000 | -54.8% | 22,387 | -13.0% | 0.00% | -50.0% |
Q3 2018 | $735,000 | +8.2% | 25,727 | +4.6% | 0.00% | 0.0% |
Q2 2018 | $679,000 | +24.8% | 24,600 | +7.4% | 0.00% | 0.0% |
Q1 2018 | $544,000 | +7.9% | 22,900 | -2.1% | 0.00% | 0.0% |
Q4 2017 | $504,000 | 0.0% | 23,400 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $504,000 | +10.3% | 23,400 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $457,000 | -27.0% | 23,400 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $626,000 | +35.8% | 23,400 | -7.9% | 0.01% | +20.0% |
Q4 2016 | $461,000 | -4.9% | 25,400 | +8.1% | 0.01% | 0.0% |
Q3 2016 | $485,000 | -18.8% | 23,500 | 0.0% | 0.01% | -28.6% |
Q2 2016 | $597,000 | -6.1% | 23,500 | -2.5% | 0.01% | -12.5% |
Q1 2016 | $636,000 | -32.2% | 24,100 | +10.6% | 0.01% | -27.3% |
Q4 2015 | $938,000 | +64.6% | 21,800 | +1.4% | 0.01% | +57.1% |
Q3 2015 | $570,000 | -17.4% | 21,500 | +3.9% | 0.01% | -12.5% |
Q2 2015 | $690,000 | +3.6% | 20,700 | +3.5% | 0.01% | 0.0% |
Q1 2015 | $666,000 | -26.8% | 20,000 | -10.7% | 0.01% | -27.3% |
Q4 2014 | $910,000 | +10.0% | 22,400 | -8.2% | 0.01% | 0.0% |
Q3 2014 | $827,000 | +2.6% | 24,400 | +2.1% | 0.01% | -8.3% |
Q2 2014 | $806,000 | -15.3% | 23,900 | -4.8% | 0.01% | -20.0% |
Q1 2014 | $952,000 | +42.1% | 25,100 | +8.2% | 0.02% | +36.4% |
Q4 2013 | $670,000 | -13.7% | 23,200 | +2.2% | 0.01% | -21.4% |
Q3 2013 | $776,000 | – | 22,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
JNBA Financial Advisors | 1 | $0 | 0.00% |